Loading clinical trials...
Loading clinical trials...
This protocol allows for the treatment of pediatric patients, male and female, between the ages of 2 months and 17 years. Patients must have failed steroid treatment for Grade B-D acute GVHD.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mesoblast, Inc.
NCT06008808 · Graft Vs Host Disease, Graft-versus-host-disease, and more
NCT00106925 · Graft-versus-leukemia, Graft vs Host Disease, and more
NCT07070674 · Acute Graft-versus-Host Disease
NCT00001529 · Graft-Versus-Host Disease, Graft-versus-leukemia, and more
NCT06910969 · Bone Marrow Transplant Complications, Graft-versus-Host Disease
Phoenix Children's Hospital
Phoenix, Arizona
Children's Hospital of Orange County
Orange, California
UCSF
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions